| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 8558G7RUTR |
| InChI Key | LCTONWCANYUPML-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C3H4O3 |
| Molecular Weight | 88.06 |
| AlogP | -0.34 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 54.37 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 6.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | 15.92 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -10.91--10.78 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC16 family of monocarboxylate transporters
|
- | - | - | 80000 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | 26000000 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | - | - | 11900000-12022644.35 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Glaucoma, Open-Angle | 2 | D005902 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 32816 |
| ChEMBL | CHEMBL1162144 |
| DrugBank | DB00119 |
| EPA CompTox | DTXSID2021650 |
| FDA SRS | 8558G7RUTR |
| Human Metabolome Database | HMDB00243 |
| Guide to Pharmacology | 4809 |
| KEGG | C00022 |
| PDB | PYR |
| PharmGKB | PA164778686 |
| PubChem | 1060 |
| SureChEMBL | SCHEMBL1750 |
| ZINC | ZINC000001532517 |